INCY compared with TRDA: revenue, margins and what each company keeps, and the suppliers and customers both name

INCYIncyte Corp

Mkt capRevenueRevenue

TRDAEntrada Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

INCYIncyte Corp

TRDAEntrada Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

INCY

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±7.5%▼−0.06%×0.01

Q2 FY26±7.4%▲+9.30%×1.26

Q1 FY26±6.9%▲+2.12%×0.30

Feb 10 '26±6.2%▼−8.24%×1.32

TRDA

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±56.7%▼−2.49%×0.04

May 7 '26±24.3%▼−57.27%×2.36

= impliedINCY realized, solidTRDA realized, hatchedOne scale, both sides: full bar = 58%× = |realized| ÷ impliedSource: market data

Q1 FY26

±38.0%

▲+6.76%

×0.18

Jan 8 '26±42.8%▼−2.14%×0.05

INCYIncyte Corp

120.41▲+3.09%· post 120.41

Mkt cap$24.5BRevenue$1.6BQ3 FY26Revenue$5.1BFY25

TRDAEntrada Therapeutics, Inc.

4.53▲+2.88%· post 4.53

ClosedOct 30 '26

Mkt cap$176.6MRevenue$898,000Q2 FY26Revenue$25MFY25

Compare

ClosedOct 30 '26

INCYIncyte Corp

TRDAEntrada Therapeutics, Inc.

120.41▲+3.09%post 120.41

Price

4.53▲+2.88%post 4.53

$24.5B

Mkt cap

$176.6M

Q3 FY26$1.6B

Revenue

$898,000Q2 FY26

FY25$5.1B

Revenue

$25MFY25

INCY120.41▲+3.09%vsTRDA4.53▲+2.88%ClosedOct 30 '26